Apollo Hospitals Enterprise financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹7,044cr+20.6% on Q1 FY26
Net profit
₹610cr+38.4% on Q1 FY26
EBITDA margin
15.5%+0.9 pts on Q1 FY26
EPS
₹40.39+34.2% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue7,0445,842+20.6%
EBITDA1,092852+28.2%
EBITDA margin15.5%14.6%+0.9 pts
Profit before tax785569+38.0%
Net profit610441+38.4%
EPS₹40.39₹30.10+34.2%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹7,044 crNet profit₹610 crNet margin8.7%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,17,010————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1,8281,8282,0101,190726
494494441385334
5,6595,6595,2753,1622,710
1,21,335————
26,43025,22921,79419,05916,612
—+15.8%+14.3%+14.7%—
4,0103,7693,0222,3912,050
15.2%14.9%13.9%12.5%12.3%
3,1132,8932,2641,7041,434
2,1722,0031,505935845
8.2%7.9%6.9%4.9%5.1%
₹145.31₹135.03₹100.55₹62.49₹56.96
—+34.3%+60.9%+9.7%—
—2,8562,1361,9201,377
—−1,962−1,713−1,137−1,129
894894424784249
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

APOLLOHOSP₹8,137.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.17L Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————1,17,010.1
- Cash, Equiv & ST Investments725.61,189.52,010.41,827.81,827.8
+ Minority Interest334.1385.1440.6494.4494.4
+ Total Debt2,710.33,161.95,275.25,658.55,658.5
Enterprise Value————1,21,335.2
Revenue16,612.519,059.221,794.025,228.526,429.9
Growth %, YoY—+14.7+14.3+15.8—
EBITDA2,049.62,390.73,021.83,769.34,009.5
Margin %12.3412.5413.8714.9415.17
EBIT1,434.41,703.72,264.32,893.23,113.0
Net Income844.6935.01,505.12,002.72,172.0
Margin %5.084.916.917.948.22
EPS, Adj (current shares)56.9662.49100.55135.03145.31
Growth %, YoY—+9.7+60.9+34.3—
Cash from Operations1,377.11,920.32,136.42,855.7—
Capital Expenditures-1,128.5-1,136.8-1,712.7-1,962.0—
Free Cash Flow248.5783.5423.7893.7893.7
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 145%.

Apollo Hospitals Enterprise financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Apollo Hospitals Enterprise (NSE: APOLLOHOSP) had a market capitalisation of ₹1,17,916 crore at the 29 October 2026 close (₹8,200.00 a share), a PE ratio of 56.4 on the last four quarters' profit and a price-to-book ratio of 12.44. In FY26 its consolidated net profit attributable to shareholders was ₹1,942 crore on revenue of ₹25,229 crore; in Q1 FY27 (April–June 2026) it was ₹581 crore, up 34.2% year on year. Its debt-to-equity ratio was 0.57 on 31 March 2026. Promoters held 28.02% of the shares on 30 September 2026.

Share price used
₹8,200.00 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026
Share price and live chart
₹8,200.00 · 29 Oct close

Apollo Hospitals Enterprise at a glance · consolidated

Market cap
₹1,17,916 Crat ₹8,200.00 · 29 Oct close
PE ratio (last 4 quarters)
56.460.7 on FY26 profit
Price to book (PB)
12.44book value ₹659.26 a share
ROE (FY26)
22.0%+2.9 pts vs FY25ROCE 18.2%
Debt to equity
0.57net debt ₹3,525 Cr
Promoter holding
28.02%unchanged vs 30 Jun 202630 September 2026
Dividend yield
0.24%₹20 a share in 12 months
Net worth
₹9,480 Cr+15.4% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹894 Cr+110.9% vs FY25

Questions

What is the Apollo Hospitals Enterprise PE ratio today?

Apollo Hospitals Enterprise's PE ratio is 56.4 at the 29 October 2026 close (₹8,200.00 a share): a market capitalisation of ₹1,17,916 crore divided by consolidated net profit attributable to shareholders of ₹2,090 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹1,942 crore) it is 60.7.

What is the Apollo Hospitals Enterprise PB ratio (price to book value)?

Apollo Hospitals Enterprise's price-to-book (PB) ratio is 12.44 at the 29 October 2026 close: a market capitalisation of ₹1,17,916 crore divided by shareholders' equity (book value) of ₹9,480 crore on 31 March 2026. That is a book value of ₹659.26 per share against a share price of ₹8,200.00.

What is the Apollo Hospitals Enterprise net worth?

Apollo Hospitals Enterprise's net worth — shareholders' equity in its consolidated balance sheet — was ₹9,480 crore on 31 March 2026, up 15.4% from ₹8,212 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,17,916 crore at the 29 October 2026 close.

What is the Apollo Hospitals Enterprise market cap?

Apollo Hospitals Enterprise's market capitalisation was ₹1,17,916 crore (₹1.18 lakh crore) at the 29 October 2026 close: 14.38 crore shares at ₹8,200.00 each.

Is Apollo Hospitals Enterprise debt free?

No. Apollo Hospitals Enterprise had borrowings of ₹5,659 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.57. Its cash and current investments were ₹2,133 crore, so its net debt was ₹3,525 crore.

What is the Apollo Hospitals Enterprise EPS?

Apollo Hospitals Enterprise's basic earnings per share (EPS) were ₹135.04 in FY26, against ₹100.56 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹145.34.

What is the Apollo Hospitals Enterprise debt to equity ratio?

Apollo Hospitals Enterprise's debt-to-equity ratio was 0.57 on 31 March 2026: borrowings of ₹5,659 crore against total equity of ₹9,975 crore. A year earlier, on 31 March 2025, it was 0.61.

What is the Apollo Hospitals Enterprise dividend in 2026 and its record date?

In 2026, Apollo Hospitals Enterprise has declared two dividends totalling ₹20 a share: ₹10 (interim) with record date 16 February 2026 and ₹10 with record date 14 August 2026.

What is the Apollo Hospitals Enterprise promoter holding?

Promoters held 28.02% of Apollo Hospitals Enterprise on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

What is the Apollo Hospitals Enterprise ROE and ROCE?

In FY26, Apollo Hospitals Enterprise's return on equity (ROE) was 22.0% and its return on capital employed (ROCE) was 18.2%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 19.1% and ROCE 16.1%.

What is the Apollo Hospitals Enterprise dividend yield?

Apollo Hospitals Enterprise's dividend yield is 0.24% at the 29 October 2026 close: dividends of ₹20 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹8,200.00. They were ₹10 on 14 August 2026 and ₹10 on 16 February 2026 (interim).

What is the Apollo Hospitals Enterprise shareholding pattern?

On 30 September 2026, Apollo Hospitals Enterprise's shares were held by promoters 28.02%, foreign portfolio investors (FII/FPI) 43.18%, domestic institutions (DII) 22.07% (including mutual funds at 17.19%) and retail and other non-institutional investors 6.49%. Over the year, FII holding was down 1.02 percentage points from 44.20% and DII holding was up 0.95 percentage points from 21.12%.

What is the Apollo Hospitals Enterprise book value per share?

Apollo Hospitals Enterprise's book value per share was ₹659.26 on 31 March 2026: shareholders' equity of ₹9,480 crore divided by the 14.38 crore shares in issue. The share price at the 29 October 2026 close was ₹8,200.00.

What is the Apollo Hospitals Enterprise free cash flow?

In FY26, Apollo Hospitals Enterprise generated ₹2,856 crore of cash from operations and spent ₹1,962 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹894 crore. In FY25 it was ₹424 crore.

What are the Apollo Hospitals Enterprise latest quarterly results?

Apollo Hospitals Enterprise's latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: consolidated net profit attributable to shareholders ₹581 crore, up 34.2% from ₹433 crore in Q1 FY26; revenue from operations ₹7,044 crore, up 20.6% year on year.

What is the Apollo Hospitals Enterprise revenue and profit in FY26?

In FY26 (April 2025–March 2026), Apollo Hospitals Enterprise's consolidated net profit attributable to shareholders was ₹1,942 crore, up 34.3% from ₹1,446 crore in FY25, on revenue from operations of ₹25,229 crore (up 15.8%). Over three years, from FY23, net profit was up 137.1%.

When are the Apollo Hospitals Enterprise next results?

Apollo Hospitals Enterprise will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.

Apollo Hospitals Enterprise vs Fortis Healthcare: how do they compare?

In FY26, Apollo Hospitals Enterprise earned net profit attributable to shareholders of ₹1,942 crore on revenue of ₹25,229 crore, against ₹1,042 crore on ₹9,128 crore for Fortis Healthcare. Apollo Hospitals Enterprise's operating margin was 11.5% (Fortis Healthcare 17.9%) and its return on equity 22.0% (Fortis Healthcare 11.1%).

How does Apollo Hospitals Enterprise compare with its peers?

On FY26 consolidated figures, against Fortis Healthcare, Max Healthcare Institute and Global Health: Apollo Hospitals Enterprise's operating margin of 11.5% is the lowest of the four (Fortis Healthcare 17.9%, Max Healthcare Institute 21.5%, Global Health 15.8%; peer average 18.4%); its return on equity of 22.0% is the highest of the four (Fortis Healthcare 11.1%, Max Healthcare Institute 14.3%, Global Health 15.2%; peer average 13.5%); its revenue growth over three years of 14.9% a year is the third highest of the four (Fortis Healthcare 13.2% a year, Max Healthcare Institute 22.4% a year, Global Health 17.9% a year; peer average 17.8% a year).

Where do these Apollo Hospitals Enterprise figures come from?

From Apollo Hospitals Enterprise's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.